These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 3965500)

  • 21. [Hereditary or acquired angioedema caused by functional deficiency of C1 inhibitor--a still unfamiliar disease picture].
    Wüthrich B; Devay J; Späth P
    Schweiz Med Wochenschr; 1999 Feb; 129(7):285-91. PubMed ID: 10093876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and function of C1 inhibitor.
    Davis AE
    Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema.
    Kramer J; Rosen FS; Colten HR; Rajczy K; Strunk RC
    J Clin Invest; 1993 Mar; 91(3):1258-62. PubMed ID: 8450054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in the C1 inhibitor gene that result in hereditary angioneurotic edema.
    Davis AE; Bissler JJ; Cicardi M
    Behring Inst Mitt; 1993 Dec; (93):313-20. PubMed ID: 8172583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A familial case of hereditary angioneurotic edema in Japan.
    Yamato H; Nakashima Y; Ninomiya K; Sakurai S; Kuroiwa A
    Intern Med; 1992 Mar; 31(3):353-6. PubMed ID: 1611187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.
    Prandini MH; Reboul A; Colomb MG
    Biochem J; 1986 Jul; 237(1):93-8. PubMed ID: 3099750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A de novo deletion in the C1 inhibitor gene in a case of sporadic hereditary angioneurotic edema.
    Ariga T; Hoshioka A; Kohno Y; Sakamaki T; Matsumoto S
    Clin Immunol Immunopathol; 1993 Oct; 69(1):103-5. PubMed ID: 8403537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes.
    Joseph K; Bains S; Tholanikunnel BG; Bygum A; Aabom A; Koch C; Farkas H; Varga L; Ghebrehiwet B; Kaplan AP
    Allergy; 2015 Jan; 70(1):115-9. PubMed ID: 25186184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay.
    Kaplan AP; Gruber B; Harpel PC
    Blood; 1985 Sep; 66(3):636-41. PubMed ID: 3875374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro interaction of C1-inhibitor with thrombin.
    Cugno M; Bos I; Lubbers Y; Hack CE; Agostoni A
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):253-60. PubMed ID: 11460008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of hereditary angioneurotic edema provoked by functional insufficiency of C1-inactivator].
    Didkovskiĭ NA; Paskhina TS; Rabinovich SE; Nartikova VF; Dvoretskiĭ LI
    Ter Arkh; 1989; 61(6):116-9. PubMed ID: 2799695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ELISA to measure neutralizing capacity of anti-C1-inhibitor antibodies in plasma of angioedema patients.
    Engel R; Rensink I; Roem D; Brouwer M; Kalei A; Perry D; Zeerleder S; Wouters D; Hamann D
    J Immunol Methods; 2015 Nov; 426():114-9. PubMed ID: 26318839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase.
    Brower MS; Harpel PC
    J Biol Chem; 1982 Aug; 257(16):9849-54. PubMed ID: 6980881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases.
    Zahedi R; Wisnieski J; Davis AE
    J Immunol; 1997 Jul; 159(2):983-8. PubMed ID: 9218620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hereditary angioneurotic edema: a molecular disease caused by a defect in the O-glycosylation of C1 esterase inhibitor (C1-INH)].
    Ollier-Hartmann MP; Strecker G; Montreuil J; Hartmann L
    C R Acad Sci III; 1984; 299(16):667-9. PubMed ID: 6440668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cold enhancement of blood coagulation: observations on the role of C1(-)-inhibitor.
    Donaldson VH
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():41-7. PubMed ID: 6587742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site.
    Parad RB; Kramer J; Strunk RC; Rosen FS; Davis AE
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6786-90. PubMed ID: 2118657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of C1-inhibitor functional activities by immunodiffusion assay in plasma of patients with hereditary angioedema--evidence of a functionally critical level of C1-inhibitor concentration.
    Späth PJ; Wüthrich B; Bütler R
    Complement; 1984; 1(3):147-59. PubMed ID: 6443347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.